New Jersey A4311 requires Medicaid coverage for remote stress tests for pregnant women.

New Jersey A4311 mandates that the Medicaid Program include coverage for non-stress tests for pregnant women with high-risk pregnancies. These tests, approved by the U.S. Food and Drug Administration for at-home use, monitor fetal and maternal heart rate and uterine activity. The bill aims to address the issue where only 40% of high-risk pregnant women undergo prescribed contraction stress tests, which can worsen health issues and contribute to maternal mortality. By allowing for at-home testing, the bill seeks to improve access and outcomes for these women.

New Jersey A4311 requires Medicaid coverage for remote stress tests for pregnant women.

New Jersey A4311 mandates that the Medicaid Program include coverage for non-stress tests for pregnant women with high-risk pregnancies. These tests, approved by the U.S. Food and Drug Administration for at-home use, monitor fetal and maternal heart rate and uterine activity. The bill aims to address the issue where only 40% of high-risk pregnant women undergo prescribed contraction stress tests, which can worsen health issues and contribute to maternal mortality. By allowing for at-home testing, the bill seeks to improve access and outcomes for these women.